Yusuf Pathan failed dope test, suspended by BCCI
Indian all-rounder Yusuf Pathan is reportedly fail the dope test, became the second Indian cricketer to do so. According to sources, the all-rounder took a medicine named Brozeet after he felt unwell but eventually failed in the Therapeutic Use Exemption test.
“There was a substance which was in the medicine which falls under the banned list. He took that particular medicine on the advice of the team doctor. He was not aware that the medicine he took had something which was banned,” the source said.
He was discarded from the national team quite a long time ago and has played a single match in the Ranji Trophy this season. It is now known that BCCI instructed the state association not to take Pathan in the team after he failed the dope test.
The specified medicine, Terbutaline, is a bronchodilator and is taken when people have trouble breathing or for medical condition such as asthma. It is also present in commonly-used expectorants administered for cough and cold.
A BCCI release revealed, “Mr. Pathan responded to the charge by admitting the ADRV and asserting that it was caused by his ingestion of a medication containing Terbutaline that had been mistakenly given to him instead of the medication prescribed for him, which did not contain any prohibited substance.”
“The BCCI is satisfied with Pathan’s explanation that he had taken Terbutaline inadvertently to treat an Upper Respiratory Tract Infection (URTI) and not as a performance-enhancing drug. Having considered all of the evidence and taken expert external advice, the BCCI has accepted Pathan’s explanation of the cause of his ADRV, and on that basis has agreed that a period of ineligibility of five months should apply, together with the disqualification of certain results,” it added.